Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

FDA Approves Sodium Nitrite Injection for the Treatment of Cyanide Poisoning

By Pharmaceutical Processing | April 12, 2012

Hope Pharmaceuticals today announced that the FDA approved Hope’s Sodium Nitrite Injection for sequential use with sodium thiosulfate for the treatment of cyanide poisoning that is judged to be life-threatening.

Hope is the only supplier of Sodium Nitrite Injection that has been approved by the FDA.

Drugs containing sodium nitrite have been marketed in the United States without FDA approval and reportedly conform to an industry specification originally published prior to 1970 that lists only five tests.

FDA requires new drugs to meet more stringent quality requirements.

The new FDA quality specification for sodium nitrite lists 27 tests, including many recent quality advancements such as limits on bacterial, chemical, degradation, and processing impurities. To comply with the new FDA-imposed requirements, Hope utilizes custom-manufactured, ultra-pure sodium nitrite as the ingredient in its FDA-approved medication.

“Critically-ill patients should receive only high quality medications,” said Dr. Craig Sherman, Medical Director of Hope Pharmaceuticals. “Doctors should consider quality when choosing products from different manufacturers and choose an FDA-approved product whenever one is available. For the first time, doctors can choose to use an FDA-approved Sodium Nitrite Injection that complies with 2012 quality standards.” Hope’s Sodium Nitrite Injection (NDC 60267-311-10) is packaged in a 10 mL vial containing 300 mg of sodium nitrite. It is now available in a carton containing one vial or in an FDA-approved kit (Nithiodote5/8 NDC 60267-812-00) which also contains a vial of Sodium Thiosulfate Injection.

 

 

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE